Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Aquaculture Vaccines Market Analysis & Forecast to 2024-2034: Market By Product; By Route Of Administration; By Application; and By Region" report has been added to ResearchAndMarkets.com's offering.
This market analysis report examines the prospects of the global aquaculture vaccines market. According to the insightful study, the market, which stood at USD 0.412 billion in 2023, is projected to flourish, reaching an estimated USD 1.01 billion by 2034. This impressive growth trajectory, forecasted to register a CAGR of 8.47% during the period of 2024-2034, underscores the burgeoning demands of the aquaculture industry and the innovations driving vaccine development.
The report's segment-wise dissection reveals inactivated vaccines as the dominant product category, attributed to strategic partnerships bolstering the segment's expansion. The efficacy of these vaccines in maintaining the original antigenic properties despite inactivation has garnered significant attention from industry leaders, as highlighted by recent investments in immunization research and development.
Injected vaccines have emerged as the leading route of administration in terms of revenue generation, capitalizing on their ability to effectively incite immune responses in aquatic species. Innovations and acquisitions among key players are propelling this segment's dominance, with companies like Zoetis Inc. playing a pivotal role through strategic consolidations.
Delving deeper into applications, bacterial infections in aquatic animals remain a primary focus, with the segment claiming the top spot in revenue contribution. High levels of investment drive this sector, leveraging advanced molecular technologies to combat prevalent aquatic diseases.
Geographically, the North American market stands at the forefront, largely due to governmental support and active participation from the private sector in research initiatives. In contrast, the Asia Pacific region is forecasted to experience the swiftest growth rate due to a surge in aquaculture practices and government-led initiatives in water-rich countries like India.
The comprehensive report provides an in-depth analysis of the aquaculture vaccines market, segmented meticulously for a clear understanding of the various facets influencing its growth:
- By Product: Spotlighting attenuated live vaccines, recombinant vaccines, inactivated vaccines, subunit vaccines, and DNA vaccines
- By Route of Administration: Dissecting immersion & spray, injected, and oral methods of vaccine delivery
- By Application: Focusing on viral, parasitic, and bacterial segments
- By Region: A geographical breakdown including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
The report elucidates critical trends and growth drivers such as the rise of collaborative efforts for vaccine distribution, continuous advancements in vaccine technology, and escalating incidences of diseases in aquatic animals. It serves as a valuable tool for business strategists, product managers, and industry analysts to navigate the evolving dynamics of the aquaculture vaccines market.
Regional Highlights and Emerging Trends
Detailing regional insights, the report underscores pivotal developments across key areas, including:
- North America's: Concerted research efforts and strategic acquisitions shaping the vaccine landscape
- Asia Pacific's: Rapid market growth energized by sustainable aquaculture investments and governmental endorsements
Fueled by a growing demand for aquatic animal-derived products like protein powders, oils, and premium caviar, the market analysis anticipates substantial opportunities for stakeholders. The report emphasizes the importance of enhanced vaccination programs and the push towards mitigating antimicrobial resistance as catalysts for market growth, making it an indispensable resource for those charting their course in the aquaculture vaccines domain.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023-2034 |
| Estimated Market Value (USD) in 2023 | $0.41 Billion |
| Forecasted Market Value (USD) by 2034 | $1.01 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
Companies Mentioned
- Kyoto Biken Laboratories Inc.
- Zoetis
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- KBNP
- HIPRA
- Nisseiken Co. Ltd.
- Elanco
- CAVAC
- Vaxxinova International B.V.
For more information about this report visit https://www.researchandmarkets.com/r/abpryw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
